2016-03-10T00:00:00.000-05:00
Exchange Commission,0.371943
Creative Planning,0.236841
Wright Investors Service,0.445262
strong buy rating,0.465853
recent quarter,0.628205
Investors Service Inc.,0.445262
consensus price target,0.483416
hold rating,0.381543
InvestorPlace Broker Center,0.555736
research report,0.396794
biopharmaceutical company,0.467321
12-month high,-0.491454
Lau Associates,0.35994
personal trading style,0.598412
research-based biopharmaceutical company,0.642682
ex-dividend date,-0.378179
Stillwater Investment Management,0.334607
Gilead Sciences Inc.,0.555178
period,0.120193
Credit Suisse,0.309162
average price,-0.215333
consensus estimate,0.431051
shares,0.0349135
concise daily summary,0.447788
Gilead Sciences,0.420767
stock broker,0.245696
mid-day trading,-0.36305
consensus rating,0.443698
Natixis Asset Management,0.367216
chronic hepatitis,-0.646567
quarter,-0.00812525
